We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
1:00 AM – 2:00 AM
(PDT)
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Oncology
-
Company Presentation
- Multiple Therapeutics
-
Company Presentation
- Oncology
-
Company Presentation
- Immunology
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- Food and Agriculture
-
Company Presentation
- Oncology
-
Company Presentation
- Platform for Therapeutics
-
Company Presentation
- Oncology
-
Company Presentation
- Platform for Therapeutics
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- Animal Health Products
-
Company Presentation
- CNS/Neurological
-
Company Presentation
-
Company Presentation
- Multiple Therapeutics
-
Company Presentation
- Multiple Therapeutics
-
Company Presentation
- Pain Management
-
Company Presentation
- Oncology
-
Company Presentation
- Tools/Drug Development Support Tech
-
Company Presentation
- Immunology
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Infectious Disease and Vaccines
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Multiple Therapeutics
-
Company Presentation
- Metabolic Diseases
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Platform for Therapeutics
-
Company Presentation
-
Company Presentation
- Oncology
-
Company Presentation
- Immunology
-
Company Presentation
- Pain Management
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Oncology
-
Company Presentation
- Oncology
-
Company Presentation
- Orphan and Rare Disease
-
Company Presentation
- Regenerative Medicine
-
Company Presentation
-
Company Presentation
- Metabolic Diseases
-
Company Presentation
- Multiple Therapeutics
-
Company Presentation
- Multiple Therapeutics
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Oncology
-
Company Presentation
- Immunology
-
Company Presentation
- Oncology
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Orphan and Rare Disease
-
Company Presentation
- Immunology
-
Company Presentation
-
Company Presentation
- Multiple Therapeutics
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- Platform for Therapeutics
-
Company Presentation
- Regenerative Medicine
-
Company Presentation
- Oncology
-
Company Presentation
- Oncology
-
Company Presentation
- Tools/Drug Development Support Tech
-
Company Presentation
- Platform for Therapeutics
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Oncology
-
Company Presentation
- Oncology
-
Company Presentation
- Multiple Therapeutics
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Tools/Drug Development Support Tech
-
Company Presentation
- Oncology
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- Other
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- Platform for Therapeutics
-
Company Presentation
- Other
-
Company Presentation
- Regenerative Medicine
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Cardiovascular
-
Company Presentation
- Immunology
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- Tools/Drug Development Support Tech
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Oncology
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Multiple Therapeutics
-
Company Presentation
- Regenerative Medicine
-
Company Presentation
- CNS/Neurological
-
Company Presentation
- Cell and Gene Therapy and Genome Editing
-
Company Presentation
- Immunology
-
Company Presentation
- Cardiovascular
-
Company Presentation
- Immunology
-
Company Presentation
- Animal Health Products
-
Company Presentation
- Other
9:00 AM – 12:00 PM
(PDT)
-
Breakout Session
- Infectious Disease and Vaccines
9:05 AM – 9:40 AM
(PDT)
9:45 AM – 10:40 AM
(PDT)
10:45 AM – 11:30 AM
(PDT)
11:35 AM – 11:55 AM
(PDT)
12:00 PM – 1:00 PM
(PDT)
-
Special Program
- Emerging Opportunities in Global Markets
1:45 PM – 2:45 PM
(PDT)
-
Breakout Session
- Next Generation Biotherapeutics
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Patient Advocacy
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- AI and Digital Health
-
Fireside ChatFireside Chat
- Business Development and Finance
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Infectious Disease and Vaccines
3:00 PM – 4:00 PM
(PDT)
-
Breakout Session
- Patient Advocacy
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Emerging Opportunities in Global Markets
-
Fireside Chat
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Orphan and Rare Disease
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Next Generation Biotherapeutics
-
Special Program
- Cell and Gene Therapy and Genome Editing
4:15 PM – 5:15 PM
(PDT)
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Business Development and Finance
-
Fireside Chat
-
Special Program 25ABC
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Emerging Opportunities in Global Markets
-
Breakout Session
- Next Generation Biotherapeutics
10:30 AM – 4:10 PM
(PDT)
11:00 AM – 12:00 PM
(PDT)
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Next Generation Biotherapeutics
-
Breakout Session
- Brain Health
1:45 PM – 2:30 PM
(PDT)
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Intellectual Property
-
Fireside Chat
-
NIH Support for Minority Health and Health Disparities Focused on Early-Stage Life Science CompaniesBreakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- Brain Health
-
Special Program
- Business Development and Finance
3:00 PM – 4:00 PM
(PDT)
-
Breakout Session
- Environmental Sustainability
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Next Generation Biotherapeutics
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Intellectual Property
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Diversity‚ Equity and Inclusion
4:15 PM – 5:15 PM
(PDT)
-
Breakout Session
- Environmental Sustainability
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Brain Health
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Next Generation Biotherapeutics
-
Breakout Session
- Diversity‚ Equity and Inclusion
-
Fireside Chat
11:00 AM – 12:00 PM
(PDT)
-
Achieving Commercial Success Through the National Institutes of Health's Intramural Research ProgramBreakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Orphan and Rare Disease
-
Breakout Session
- Oncology
-
Breakout Session
- Translational Research
-
Breakout Session
- Environmental Sustainability
-
Breakout Session
- Diversity‚ Equity and Inclusion
1:45 PM – 2:45 PM
(PDT)
-
Breakout Session
- Translational Research
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Orphan and Rare Disease
-
Breakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Oncology
3:00 PM – 4:00 PM
(PDT)
-
Breakout Session
- Oncology
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Translational Research
-
Breakout Session
- Value‚ Patient Access and Reimbursement
-
Breakout Session
- Oncology
-
Breakout Session
- AI and Digital Health
4:15 PM – 5:15 PM
(PDT)
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- Value‚ Patient Access and Reimbursement
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Translational Research
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Diagnostics and Personalized Medicine
9:00 AM – 10:00 AM
(PDT)
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Business Development and Finance
-
Immune System Biomarkers: Can Our Antibodies Predict How We Will React to Disease and Immunotherapy?Breakout Session
- Diagnostics and Personalized Medicine
-
Breakout Session
- Oncology
-
Breakout Session
- Clinical Trials Innovations
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Oncology
10:15 AM – 11:15 AM
(PDT)
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Oncology
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Diagnostics and Personalized Medicine
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Clinical Trials Innovations